JAK1: Tyrosine-protein kinase JAK1
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Non-membrane spanning protein tyrosine kinase that phosphorylates signal-transducing subunits of cytokine receptor complexes like IL2RB, IL10RA, IFNAR2, IL6ST, LIFR, OSMR and IL31RA.
- Drugs that act on it: 14
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Tyrosine-protein kinase JAK1 inhibitor.| Abrocitinib | Approved | — | Inhibitor | Boxed warning |
| Baricitinib | Approved | — | Inhibitor | Boxed warning |
| Brepocitinib | Approved | — | Inhibitor | — |
| Momelotinib | Approved | — | Inhibitor | — |
| Upadacitinib | Approved | — | Inhibitor | Boxed warning |
| Cerdulatinib | — | — | Inhibitor | — |
| Filgotinib | — | — | Inhibitor | — |
| GLPG-0555 | — | — | Inhibitor | — |
| Golidocitinib | — | — | Inhibitor | — |
| INCB-047986 | — | — | Inhibitor | — |
| Itacitinib | — | — | Inhibitor | — |
| Ruxolitinib | — | — | Inhibitor | Boxed warning |
| Solcitinib | — | — | Inhibitor | — |
| Tricetamide | — | — | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Autoinflammation, immune dysregulation, and eosinophilia
- 0.69
- Atopic eczema
- 0.66
- Myelofibrosis
- 0.59
- Hypothyroidism
- 0.57
- Graft versus host disease
- 0.57
- Crohn disease
- 0.56
- Acquired polycythemia vera
- 0.55
- COVID-19
- 0.54
- Vitiligo
- 0.52
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- JAK1
- Related
- Janus Kinase (JAK)
Drugs and mechanisms are from ChEMBL CHEMBL2835 (CC BY-SA 3.0). Gene name, function (UniProt P23458, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets